Seres Therapeutics Inc. | Key People and Executives
Roger J. Pomerantz
Chairman, President & Chief Executive Officer
Willard H. Dere
Independent Director
Dennis Arthur Ausiello
Independent Director
Kurt C. Graves
Independent Director
Gregory Behar
Independent Director
Lorence H. Kim
Independent Director
Richard N. Kender
Independent Director
Noubar B. Afeyan
Lead Independent Director
Roger J. Pomerantz
Chairman, President & Chief Executive Officer
Eric D. Shaff
EVP, Chief Financial & Operating Officer
Michele Trucksis
Chief Medical Officer & Executive Vice President
John G. Aunins
CTO, Executive VP-Bioprocess & Manufacturing
David N. Cook
Chief Scientific Officer & Executive VP-Research
Henry Rath
Senior Vice President-Business Development
Barbara McGovern
Vice President & Head-Medical Affairs
Carol Lewis-Cullinan
Vice President & Head-Clinical Operations
Matthew R. Henn
Senior VP, Head-Drug Discovery & Bioinformatics
Jim Weston
Vice President & Head-Regulatory Affairs
Carlo Tanzi
Head-Investor Relations & Corporate Communications
Jeff York
Vice President & Head-Human Resources
Thomas J. DesRosier
Secretary, Chief Legal Officer & Executive VP
Willard H. Dere
Independent Director
Dennis Arthur Ausiello
Independent Director
Kurt C. Graves
Independent Director
Grégory Behar
Independent Director
Lorence H. Kim
Independent Director
Richard N. Kender
Independent Director
Noubar B. Afeyan
Lead Independent Director
| Address |
200 Sidney Street
Cambridge Massachusetts 02139
United States
|
|
Employees
|
- |
| Website |
http://www.serestherapeutics.com |
| Updated |
07/08/2019 |
| Seres Therapeutics, Inc. is a microbiome therapeutics platform company, which engages in the development of biological drugs. It focuses on implementing microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. The company was founded by Geoffrey von Maltzahn, David A. |
